Skip to main content
Premium Trial:

Request an Annual Quote

Enzo, Cancer Genetics Enter into Dye Labels Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has entered into a supply and distribution deal with privately held Cancer Genetics (CGI) covering the use of Enzo Life Sciences' fluorescent dye labels for increasing signal intensity in labeling nucleic acids.

Under the non-exclusive agreement, Enzo Life Sciences will incorporate its labels into CGI's nucleic acid material that it and supplies to the research market.

Rutherford, NJ-based CGI has developed and sells DNA FISH probes and CGH microarrays for use in cancer diagnostics in the lab setting.

"This agreement enables us to offer our labeling products in conjunction with Cancer Genetics' FISH probes, which are highly regarded in the research market, and which also provide strong recognition for our technology," Carl Balezentis, president of the Enzo Life Sciences division of Enzo Biochem, said in a statement. "We also recognize that opportunities exist to expand our clinical lab offerings through the unique products and services for personalized cancer treatment being offered and being developed by CGI."

Financial and other terms of the alliance were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.